Dr Daniel Joseph Ybarra, MD, MPH | |
612 W Duarte Rd Ste 804, Arcadia, CA 91007-9250 | |
(626) 600-2094 | |
(626) 226-5827 |
Full Name | Dr Daniel Joseph Ybarra |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 612 W Duarte Rd Ste 804, Arcadia, California |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1922554245 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208600000X | Surgery | A151138 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Daniel Joseph Ybarra, MD, MPH 612 W Duarte Rd Ste 804, Arcadia, CA 91007-9250 Ph: (626) 600-2094 | Dr Daniel Joseph Ybarra, MD, MPH 612 W Duarte Rd Ste 804, Arcadia, CA 91007-9250 Ph: (626) 600-2094 |
News Archive
The death rates of individual heart surgeons have been published in England and several US states for some years. A high profile investigation into high death rates at a certain cardiac centre motivated this in England. For other surgery types, death rates have been reported only at the hospital or trust level. NHS England's "Everyone Counts" policy, introduced this Summer, means that outcomes of ten types of surgery will be reported at the individual surgeon level.
Patients who are given "take home" methadone maintenance treatment for opioid dependence are less likely to be admitted to hospital than those who do not, a study shows.
Having studied the ethical, judicial and political arguments, the Norwegian government task force has suggested that a single nationwide company should be formed to commercialise biomaterials assets from the country's various sources. The task force has also recommended HUNT Biosciences be a model for the national company.
Soligenix, Inc., a late-stage biopharmaceutical company, reported today that it has completed enrollment of its Phase 1B clinical trial of RiVax™, a ricin subunit vaccine, in healthy volunteers. Preliminary results indicate that RiVax™ appears safe at all doses tested in volunteers. This trial is designed to assess the duration of immune responses using an adjuvant formulation of RiVax™ over a period of more than one year after vaccination.
› Verified 2 days ago
Bala S Chandrasekhar, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 255 E. Santa Clara St., Suite 310, Arcadia, CA 91006 Phone: 626-447-1092 Fax: 626-447-4125 | |
Robert H Papadopoulos, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 612 W Duarte Rd, Suite 602, Arcadia, CA 91007 Phone: 626-446-4645 Fax: 626-446-1626 | |
Bengt Florian Pehrsson, MD Surgery Medicare: Medicare Enrolled Practice Location: 622 W Duarte Rd, #301, Arcadia, CA 91007 Phone: 626-445-0600 Fax: 626-574-8654 | |
Dr. Ramon Oceguera, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 622 W Duarte Rd Ste 104, Arcadia, CA 91007 Phone: 626-445-2974 Fax: 626-445-0093 | |
Troy Lamar, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 51 N Fifth Avenue, Suite 202, Arcadia, CA 91006 Phone: 626-445-0600 Fax: 626-574-8654 | |
Dr. Julius Wah Gee, DO Surgery Medicare: Not Enrolled in Medicare Practice Location: 1032 Leandra Lane, Arcadia, CA 91006 Phone: 626-230-6582 | |
William W. Tseng, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 301 W Huntington Dr Ste 400, Arcadia, CA 91007 Phone: 626-218-9840 Fax: 626-218-9860 |